- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 338.73M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 344.88M sh |
| Shares Outstanding | Q1 2026 · Mar 31, 2026 | 336.29M sh |
| Shares Outstanding | Q1 2026 · Dec 31, 2025 | 338.31M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $981.72M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $1B |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $1.29B |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $831.71M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $3.51B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $3.51B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $2.76B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $2.49B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.36B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.13B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $575.42M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $1.09B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.49B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.33B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $5.34B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $5.12B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $4.85B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $4.43B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $7.71B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $7.26B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $3.56 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $1.67 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $3.57 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $1.70 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $44.03M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $51.52M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $94.1M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $56.41M |
| Net Income | Q1 2026 · Mar 31, 2026 | $1.21B |
| Net Income | Q1 2026 · Mar 31, 2025 | $576.42M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $1.44B |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $839.98M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $203.63M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $151.68M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.84B |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $1.16B |